Core Viewpoint - The company has received a tender offer report summary from Mr. Cao Fei, which triggers a mandatory tender offer due to changes in shareholding structure [2][3][5]. Group 1: Tender Offer Details - The tender offer price is set at 26.93 yuan per share, with a total of 350,841,357 shares being offered, representing 38.06% of the company's issued shares [5][6]. - The tender offer period is 30 calendar days, during which investors can check the number of shares accepted for the offer [8]. - The offer is aimed at acquiring all freely tradable shares held by shareholders other than Mr. Cao Longxiang, Jichuan Holdings, and Tibet Jichuan [5][6]. Group 2: Shareholding Changes - Mr. Cao Longxiang plans to transfer 10.10% of his shares in Jichuan Holdings to his son, Mr. Cao Fei, making Mr. Cao Fei the controlling shareholder of Jichuan Holdings with 60% ownership [3][4]. - Following the transfer, Mr. Cao Fei and Mr. Cao Longxiang will jointly control 56.07% of the listed company, triggering the mandatory tender offer obligation [3][5]. Group 3: Financial Arrangements - The total maximum funding required for the tender offer is based on the offer price and is sourced from the acquirer's own funds and legally raised funds [7]. - Mr. Cao Fei has deposited 1.895 billion yuan as a performance guarantee for the tender offer, which is at least 20% of the total required funds [7].
济川药业: 湖北济川药业股份有限公司关于收到要约收购报告书摘要的提示性公告